As Europe has been significantly impacted by the Covid-19 pandemic, a huge amount of clinical research is focused on identifying effective therapies and vaccines. GlobalData analysed the Covid-19 clinical trials landscape in Europe with a view to identifying key trial-related trends.
The greatest proportion of European Covid-19 clinical trials are in the Phase II stage of development (43.3%). Read more here.
Go deeper with GlobalData
